1400 Seaport Blvd
Building B
Redwood City
CA
94063
USA
650.241.1221
Product Categories
Related Content
Kavitha Chinnaiyan, M.D., FACC, FSCCT, associate professor, Oakland University, William Beaumont School of Medicine ...
July 19, 2018
An interview with Patrick Serruys, M.D., Ph.D., Imperial College London, principal investigator of the SYNTAX III Trial ...
July 17, 2018
July 3, 2018 — HeartFlow Inc. announced that UnitedHealthcare now covers the HeartFlow FFRct Analysis, extending access ...
July 03, 2018
May 29, 2018 — Results from the innovative SYNTAX III Revolution Trial [1] underline the effectiveness of evolving ...
May 29, 2018
April 25, 2018 — HeartFlow Inc. announced that the National Health Service (NHS) England has chosen the HeartFlow FFRct ...
April 25, 2018
March 13, 2018 – HeartFlow, Inc. today announced that it has entered into a licensing and technology transfer agreement ...
March 13, 2018
February 1, 2018 – HeartFlow announced that seven new commercial payers issued positive medical policies covering the ...
February 01, 2018
December 28, 2017 — HeartFlow Inc. announced that Health Care Service Corp. (HCSC), which operates Blue Cross and Blue ...
December 28, 2017
November 6, 2017 – The Centers for Medicare & Medicaid Services (CMS) has finalized a New Technology Ambulatory Payment ...
November 06, 2017
October 26, 2017 — Corindus Vascular Robotics Inc. announced that it will incorporate the HeartFlow FFRct (fractional ...
October 26, 2017© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now